Delayed FLAIR-enhancement of benign notochordal remnant (ecchordosis physaliphora)
Source
The Neuroradiology Journal - ISSN 1971-4009-38:2 (2025) p. 220-223
The unjustified fear of erdafitinib-induced central serous retinopathy
Source
Annals of oncology - ISSN 0923-7534-36:8 (2025) p. 1001-1002
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years?
Source
Acta oncologica - ISSN 0284-186X-64 (2025) p. 979-988
Sacituzumab govitecan in advanced urothelial carcinoma : TROPiCS-04, a phase III randomized trial
Source
Annals of oncology - ISSN 0923-7534-36:5 (2025) p. 561-571
First-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer : a randomized, open-label, phase III trial
Source
Journal of clinical oncology - ISSN 0732-183X-43:9 (2025) p. 1-24